Exelixis
EXEL
#1825
Rank
$11.19 B
Marketcap
$41.75
Share price
1.11%
Change (1 day)
6.61%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company